Sol_75N98026Q00522.pdf

REQUEST FOR QUOTATION

(THIS IS NOT AN ORDER)

THIS RFQ IS IS NOT A SMALL BUSINESS SET-ASIDE

15. DATE OF QUOTATION

16. SIGNER

a. NAME (Type or print)

c. TITLE (Type or print)

b. TELEPHONE

AREA CODE

NUMBER

STANDARD FORM 18 (REV. 6/1995)

Prescribed by GSA-FAR (48 CFR) 53.215-1(a)

AUTHORIZED FOR LOCAL REPRODUCTION

Previous edition not usable

8. TO:

b. COMPANYa. NAME

c. STREET ADDRESS

d. CITY e. STATE f. ZIP CODE

9. DESTINATION

a. NAME OF CONSIGNEE

b. STREET ADDRESS

d. STATE e. ZIP CODE

7. DELIVERY

FOB DESTINATION

OTHER

(See Schedule)

10. PLEASE FURNISH QUOTATIONS TO THE

ISSUING OFFICE IN BLOCK 5a ON OR BEFORE CLOSE OF BUSINESS (Date)

IMPORTANT: This is a request for information and quotations furnished are not offers. If you are unable to quote, please so indicate on this form and return it to the address in Block 5a. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service. Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this Request for Quotation must be completed by the quoter.

11. SCHEDULE (Include applicable Federal, State and local taxes)

ITEM NUMBER

(a)

SUPPLIES/SERVICES

(b)

QUANTITY

(c)

UNIT

(d)

UNIT PRICE

(e)

AMOUNT

(f)

12. DISCOUNT FOR PROMPT PAYMENT

a. 10 CALENDAR DAYS (%) b. 20 CALENDAR DAYS (%) c. 30 CALENDAR DAYS (%) d. CALENDAR DAYS

NUMBER PERCENTAGE

NOTE: Additional provisions and representations are are not attached.

13. NAME AND ADDRESS OF QUOTER

a. NAME OF QUOTER

b. STREET ADDRESS

c. COUNTY

d. CITY e. STATE f. ZIP CODE

14. SIGNATURE OF PERSON AUTHORIZED TO

SIGN QUOTATION

PAGE OF PAGES

1. REQUEST NUMBER 2. DATE ISSUED 3. REQUISITION/PURCHASE REQUEST NUMBER 4. CERT. FOR NAT. DEF.

UNDER BDSA REG. 2

AND/OR DMS REG. 1

RATING

5a. ISSUED BY 6. DELIVER BY (Date)

NAME TELEPHONE NUMBER

AREA CODE NUMBER

c. CITY

5b. FOR INFORMATION CALL (NO COLLECT CALLS)

National Institutes of Health OD - Office of Logistics and Acquisition Operations 6100 Executive Blvd., Room 6B05 Bethesda, MD 20892-7511

75N98026Q00522

NICHOLAS CAPOBIANCO

+10

000-000000

06/04/2026

06/10/2026 1100 ED

Multiple

This NOI - NON-COMPETITIVE COMBINED

SYNOPSIS / SOLICITATION is to acquire continued integration of the NHLBI

Laboratory of Hemostasis & Platelet

Biology into the Framingham Heart Study

(FHS).

Period of Performance: 06/10/2026 to

06/09/2027

1 Integration Fee - For coordination and integration of ancillary studies into a single holistic examination within

Framingham Heart Study operations

Product/Service Code: R499

Product/Service Description: SUPPORT-

PROFESSIONAL: OTHER

Continued...

1 2

CONTINUATION SHEET

REFERENCE NO. OF DOCUMENT BEING CONTINUED PAGES

NAME OF OFFEROR OR CONTRACTOR

SUPPLIES/SERVICES

(B)

UNIT

(D)

UNIT PRICE

(E)

AMOUNT

(F)

OPTIONAL FORM 336 (4-86)

Sponsored by GSA FAR (48 CFR) 53.110

ITEM NO.

(A)

QUANTITY

(C)

NSN 7540-01-152-8067

75N98026Q00522

The following FAR clauses and Provisions are applicable to this award.

FAR 52.204-13 System for Award Management

Maintenance (Oct 2018);

FAR 52.204-18 Commercial and Government Entity

Code Maintenance (Aug 2020);

HHSAR 352.222-70, Contractor Cooperation in

Equal Employment Opportunity Investigations

(Dec 2015).

FAR 52.212-4 Contract Terms and Conditions -In addition to all the applicable commercial

Products and Commercial Services (Nov 2023)

FAR 52.212-5 Contract Terms and Conditions

Required to Implement Statutes or Executive

Orders/Commercial Products and Commercial

Services (Jan 2025)

FAR 52.217-8 Option to Extend Services (Nov

1999)

FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE

To avoid delay in payment, all invoices must be uploaded into the invoicing processing platform

(IPP) (https://www.ipp.gov). The invoice must match the line item description on the purchase order. It must also state that payment is to be made using a three-way match.

NOI - NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION

Title: Platelet Function Data Collection Integration Fee

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00522. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable).

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).

The National Institutes of Health (NIH) intends to award a firm-fixed-price purchase order on a non-competitive basis to Boston University, One Silber Way, Boston, MA 02215 for continued integration of the NHLBI Laboratory of Hemostasis & Platelet Biology into the Framingham Heart Study (FHS). Boston University operates the Framingham Heart Study and is the only source able to provide on-site wet-lab access to FHS participants, samples, and core de-identified participant data required for this research.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through the most recent Federal Acquisition Circular.

(iv) (iv) The associated NAICS code is 541990 (All Other Professional, Scientific, and Technical Services), and the small business size standard is $19.5 million in average annual receipts.

This requirement is not set aside for small business.

(v) Description of Requirement:

The NHLBI Laboratory of Hemostasis & Platelet Biology, part of the Population Sciences Branch, requires continued integration into the Framingham Heart Study (FHS) to support ongoing research on platelet reactivity, population variation, and genetic and epidemiological associations with platelet biology. The Laboratory has been an ancillary study at FHS for over 10 years and is currently the largest platelet biology lab in the world, having collected data on over 5,000 individuals.

Because platelet samples are highly sensitive to transport and data collection must be completed within approximately 3 hours of the blood draw, all services must be performed on-site at the FHS Performance Location. Transport of samples to another site is not acceptable.

(vi) Delivery Location:

73 Mount Wayte Ave, Suite 2 Framingham, MA 01702

(vii) [Reserved, if needed]

(viii) The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition.

(ix) The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

(a) A written notice of award or acceptance of an offer, issued to the successful offeror within the time specified in the offer, shall result in a binding contract without further action by either party.

The Government reserves the right to accept any offer (or part of an offer) before the expiration date, whether or not discussions are conducted, unless a written notice of withdrawal is received prior to award. Add additional evaluation criteria as required.

(x) Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer.

(xi) FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

(xii) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items, applies to this acquisition.

(xiii) Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices: None.

(xiv) The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.

(xv) Submission Requirements:

Responses must include sufficient information to demonstrate the respondent's capability to provide the required service, including specifically the ability to:

• Provide BSL2 wet-lab space physically located at or immediately adjacent to the Framingham Heart Study site in Framingham, MA, such that platelet data collection can be completed within 3 hours of blood draw;

• Provide phlebotomy and consenting services on enrolled FHS participants;

• Access and use de-identified Core FHS participant data;

• Coordinate with the FHS IRB, Ethics Advisory Board, and Observational Monitoring

Board.

Price quotations shall include, at a minimum: unit price, list price, shipping and handling costs (if any), delivery/performance timeframe after award, delivery terms, prompt payment discount terms, F.O.B. point, product or catalog numbers (if applicable), service descriptions, and any other relevant information.

Evaluation factors may include, but are not limited to: past performance, technical capability, special features.

Responses must also include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

All responses must be received by Wednesday, June 10, 2026 at 11:00 AM EDT and must reference solicitation number 75N98026Q00522. Responses may be submitted electronically to nicholas.capobianco@nih.gov.

This notice of intent is not a request for competitive quotations. However, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the Agency. A determination by the Government not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the Government.

mailto:nicholas.capobianco@nih.gov

Title